Skip to Main Content

Paper Details

A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protection.
Cell Rep Med
1
2023
Author NameAffiliation
Laura A VanBlarganWashington University School of Medicine
Pavlo GilchukVanderbilt University Medical Center
Rita E ChenWashington University School of Medicine
James E CroweVanderbilt University Medical Center
Michael S DiamondWashington University School of Medicine, Washington University in St. Louis, USA Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs
  • 1 - 5

Datasets